I 
119TH CONGRESS 
1ST SESSION H. R. 1671 
To amend title 38, United States Code, to provide for a presumption of 
service-connection under the laws administered by the Secretary of Vet-
erans Affairs for certain diseases associated with the COVID–19 vaccine 
that become manifest during the one-year period following the receipt 
of the vaccine, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 27, 2025 
Mr. DAVIDSON (for himself, Mr. NEHLS, Mr. MASSIE, Mrs. MILLER of Illinois, 
Mr. GOSAR, Mr. WEBER of Texas, and Mr. FALLON) introduced the fol-
lowing bill; which was referred to the Committee on Veterans’ Affairs, 
and in addition to the Committee on Armed Services, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
of such provisions as fall within the jurisdiction of the committee con-
cerned 
A BILL 
To amend title 38, United States Code, to provide for a 
presumption of service-connection under the laws admin-
istered by the Secretary of Veterans Affairs for certain 
diseases associated with the COVID–19 vaccine that be-
come manifest during the one-year period following the 
receipt of the vaccine, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
00:52 Mar 15, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H1671.IH
H1671
ssavage on LAPJG3WLY3PROD with BILLS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Justice for Vaccine 
Injured Veterans Act of 2025’’. 
SEC. 2. FINDINGS; SENSE OF CONGRESS. 
(a) FINDINGS.—Congress finds the following: 
(1) On August 24, 2021, Secretary of Defense 
Lloyd Austin issued a memorandum titled, ‘‘Manda-
tory Coronavirus Disease 2019 Vaccination of De-
partment of Defense Service Members’’. 
(2) This memorandum stated, ‘‘I therefore di-
rect the Secretaries of the Military Departments to 
immediately begin full vaccination of all members of 
the Armed Forces under DoD authority on active 
duty or in the Ready Reserve, including the National 
Guard, who are not fully vaccinated against 
COVID–19’’. 
(3) In December 2022, the Department of De-
fense reported that ‘‘98 percent of active duty serv-
ice members and 96 percent of the total force have 
been vaccinated’’ from COVID–19. 
(4) As a result of this memorandum, more than 
8,400 members of the Armed Forces were forced out 
of the military for refusing to get the COVID–19 
vaccine. 
(5) On January 10, 2023, Secretary Austin was 
forced to rescind this memorandum as a requirement 
VerDate Sep 11 2014 
00:52 Mar 15, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H1671.IH
H1671
ssavage on LAPJG3WLY3PROD with BILLS
of section 525 of the James M. Inhofe National De-
fense Authorization Act for Fiscal Year 2023 (Pub-
lic Law 117–263). 
(b) SENSE OF CONGRESS.—It is the sense of Con-
gress that the actions referred to in subsection (a) that 
were taken by the Department of Defense under the Biden 
administration caused irreparable harm to the health and 
readiness of the United States Armed Forces. 
SEC. 3. DEPARTMENT OF VETERANS AFFAIRS PRESUMP-
TION OF SERVICE-CONNECTION FOR CER-
TAIN DISEASES ASSOCIATED WITH COVID–19 
VACCINE. 
(a) IN GENERAL.—Subchapter II of chapter 11 of 
title 38, United States Code, is amended by adding at the 
end the following new section: 
‘‘§ 1120A. Presumption of service-connection for cer-
tain diseases associated with COVID–19 
vaccine 
‘‘(a) IN GENERAL.—For the purposes of section 1110 
of this title, and subject to section 1113 of this title, a 
disease specified in subsection (b) becoming manifest in 
a member of the Armed Forces who, during the period 
beginning on August 24, 2021, and ending on January 
10, 2023, received a COVID–19 vaccine under orders shall 
be considered to have been incurred in or aggravated dur-
VerDate Sep 11 2014 
00:52 Mar 15, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H1671.IH
H1671
ssavage on LAPJG3WLY3PROD with BILLS
ing active military, naval, air, or space service, notwith-
standing that there is no record of evidence of such disease 
during the period of such service. 
‘‘(b) COVERED DISEASES.—The diseases specified in 
this subsection are the following: 
‘‘(1) Myocarditis. 
‘‘(2) Pericarditis. 
‘‘(3) Thrombosis with thrombocytopenia syn-
drome. 
‘‘(4) Guillian-Barre Syndrome. 
‘‘(5) Any other disease for which the Secretary 
determines that a presumption of service connection 
is warranted based on a positive association with the 
COVID–19 vaccine. 
‘‘(c) CONGRESSIONAL NOTICE REQUIREMENT.—If 
the Secretary determines that an additional disease should 
be specified pursuant to subsection (b)(4), the Secretary 
shall submit to the Committees on Veterans Affairs’ of 
the Senate and the House of Representatives notice of 
such determination. 
‘‘(d) REPORT.—Not later than 60 days after the date 
of enactment of the Justice for Vaccine Injured Veterans 
Act of 2025, and every 60 days thereafter for the subse-
quent four year-period, the Secretary shall submit to the 
Committees of Veterans’ Affairs of the Senate and the 
VerDate Sep 11 2014 
00:52 Mar 15, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H1671.IH
H1671
ssavage on LAPJG3WLY3PROD with BILLS
House of Representatives a report that contains each of 
the following: 
‘‘(1) The total number of claims for compensa-
tion under this chapter related to a disease associ-
ated with the COVID–19 vaccine. 
‘‘(2) 
The 
status 
of 
each 
such 
claim, 
disaggregated by— 
‘‘(A) the number of claims that were ap-
proved; 
‘‘(B) the number of claims that were de-
nied and for which the claimant took no further 
action; 
‘‘(C) the number of claims that were de-
nied and for which the claimant filed a supple-
mental claim; 
‘‘(D) the number of claims that were de-
nied and for which the claimant requested a 
higher level review; and 
‘‘(E) the number of claims that were de-
nied and for which the claimant filed an appeal 
to the Board of Veterans’ Appeals. 
‘‘(3) The total number of such claims that, as 
of the date of the submission of the report, had been 
submitted but were pending a decision. 
VerDate Sep 11 2014 
00:52 Mar 15, 2025
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H1671.IH
H1671
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(e) PUBLIC ACCESS TO REPORTS.—The Secretary 
shall make each report required by subsection (d) publicly 
available, including by making publicly available on an ap-
propriate website of the Department each such report to-
gether with such additional information or comments as 
the Secretary considers appropriate to provide context for 
the report. 
‘‘(f) COVID–19 VACCINE DEFINED.—In this section, 
the term ‘COVID–19 vaccine’ means vaccine licensed 
under section 351 of the Public Health Service Act (42 
U.S.C. 262) or authorized for emergency use under sec-
tion 564 of the Federal Food, Drug, and Cosmetic Act 
(21 U.S.C. 360bbb–3) for immunization against the virus 
responsible for COVID–19.’’. 
(b) CLERICAL AMENDMENT.—The table of sections 
at the beginning of such chapter is amended by inserting 
after the item relating to section 1120 the following new 
item: 
‘‘1120A. Presumption of service-connection for certain diseases associated with 
COVID–19 vaccine.’’. 
Æ 
VerDate Sep 11 2014 
00:52 Mar 15, 2025
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H1671.IH
H1671
ssavage on LAPJG3WLY3PROD with BILLS